Many drug products, such as biosimilars, monoclonal antibodies, and growth factors, are large therapeutic molecules. These molecules have the risk of eliciting unwanted immune responses in the patient population. Factors affecting this immunogenicity drug profile include the manufacturing process, purity and size of the protein, health status of patients, and much more. Unwanted immunogenicity causes […]
Tag: NAB Assay Development
Back To Top